The Role of the Nurse Practitioner in the Treatment of mHSPC - Leanne Schimke

March 26, 2019

Leanne Schimke begins her presentation discussing the role of the nurse practitioner in the treatment of patients with advanced prostate cancer. She first looks at newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) patients. Also, presented is treatment options for mHSPC and the administration, adverse effects, nursing considerations, and drug interactions of these treatments. 


Leanne Schimke, CRNP, CUNP, dual certified Family Nurse Practitioner and a Urology Nurse Practitioner at Lancaster Urology

Diane K. Newman, DNP, ANP-BC, FAAN, Adjunct Professor of Urology in Surgery, Perelman School of Medicine, University of Pennsylvania and Co-Director of the Penn Center for Continence and Pelvic Health.